- Home
- NC vs LRMR Comparison
NC vs LRMR Comparison
Compare NC & LRMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NC
- LRMR
- Stock Information
- Founded
- NC 1913
- LRMR N/A
- Country
- NC United States
- LRMR United States
- Employees
- NC N/A
- LRMR N/A
- Industry
- NC Coal Mining
- LRMR Biotechnology: Pharmaceutical Preparations
- Sector
- NC Energy
- LRMR Health Care
- Exchange
- NC Nasdaq
- LRMR Nasdaq
- Market Cap
- NC 305.1M
- LRMR 309.8M
- IPO Year
- NC N/A
- LRMR N/A
- Fundamental
- Price
- NC $41.00
- LRMR $4.74
- Analyst Decision
- NC
- LRMR Strong Buy
- Analyst Count
- NC 0
- LRMR 7
- Target Price
- NC N/A
- LRMR $16.71
- AVG Volume (30 Days)
- NC 11.4K
- LRMR 4.4M
- Earning Date
- NC 10-29-2025
- LRMR 10-29-2025
- Dividend Yield
- NC 2.49%
- LRMR N/A
- EPS Growth
- NC N/A
- LRMR N/A
- EPS
- NC 4.23
- LRMR N/A
- Revenue
- NC $265,880,000.00
- LRMR N/A
- Revenue This Year
- NC N/A
- LRMR N/A
- Revenue Next Year
- NC N/A
- LRMR N/A
- P/E Ratio
- NC $9.86
- LRMR N/A
- Revenue Growth
- NC 27.25
- LRMR N/A
- 52 Week Low
- NC $26.15
- LRMR $1.61
- 52 Week High
- NC $45.50
- LRMR $9.50
- Technical
- Relative Strength Index (RSI)
- NC 48.29
- LRMR 56.30
- Support Level
- NC $40.78
- LRMR $3.10
- Resistance Level
- NC $42.00
- LRMR $4.99
- Average True Range (ATR)
- NC 1.62
- LRMR 0.52
- MACD
- NC -0.31
- LRMR 0.03
- Stochastic Oscillator
- NC 9.40
- LRMR 70.48
About NC NACCO Industries Inc.
NACCO Industries Inc is a holding company that operates in the mining and natural resource industries. It has three operating segments that are coal mining, North American mining (NA mining), and minerals management. The majority of its revenue is from the coal mining segment. This segment operates surface coal mines under long-term contracts with power generation companies and an activated carbon producer pursuant to a service-based business model. The NA mining segment provides value-add contract mining and services for producers. Minerals management generates income from royalty-based leases by acquiring and promoting oil, gas, and coal mineral interests. The company is diversifying beyond coal mining due to political and economic pressures associated with carbon emissions.
About LRMR Larimar Therapeutics Inc.
Larimar Therapeutics Inc is a clinical-stage biotechnology company focused on developing treatments for patients suffering from complex rare diseases using its novel cell-penetrating peptide (CPP) technology platform. Its lead product candidate, CTI-1601, is a subcutaneously administered, recombinant fusion protein intended to deliver human frataxin (FXN) an essential protein, to the mitochondria of patients with Friedreich's ataxia.